When should we put evidence into clinical practice?
作者信息
Türktaş Ipek, Bakirtas Arzu, Tapisiz Anil
出版信息
J Allergy Clin Immunol. 2011 Apr;127(4):1078; author reply 1078-9. doi: 10.1016/j.jaci.2010.12.1100.
PMID:21306760
Abstract
摘要
相似文献
1
When should we put evidence into clinical practice?
J Allergy Clin Immunol. 2011 Apr;127(4):1078; author reply 1078-9. doi: 10.1016/j.jaci.2010.12.1100.
2
Can we prevent exacerbations of asthma caused by common cold viruses?
J Allergy Clin Immunol. 2010 Oct;126(4):770-1. doi: 10.1016/j.jaci.2010.08.019.
3
The immunostimulant OM-85 BV prevents wheezing attacks in preschool children.
J Allergy Clin Immunol. 2010 Oct;126(4):763-9. doi: 10.1016/j.jaci.2010.07.038.
4
[Clinical study concerning the prevention of infections of the upper respiratory tract of preschool children].
Schweiz Rundsch Med Prax. 1982 Sep 7;71(36):1385-9.
5
Bacterial immunostimulants--mechanism of action and clinical application in respiratory diseases.
Pneumonol Alergol Pol. 2008;76(5):353-9.
6
[The use of broncho-vaxom preparation in clinical practice].
Pol Merkur Lekarski. 2003 May;14(83):457-8.
7
[Broncho-Vaxom in the treatment of recurrent respiratory tract infections in children].
Pneumonol Pol. 1986 Jun;54(6):231-5.
8
[Treatment of recurrent respiratory diseases using bacterial vaccines].
Cesk Pediatr. 1988 Dec;43(12):738-40.
9
Immunomodulators and primary prevention of respiratory infections: methodological considerations.
Dev Biol Stand. 1992;77:159-65.
10
Are responses to treatment virus-specific in wheezing children?
J Allergy Clin Immunol. 2007 Jun;119(6):1561-2. doi: 10.1016/j.jaci.2007.02.008. Epub 2007 Apr 6.
Zotero 插件